Calbindin 1, clusterin, GSTP1, KIM-1, and MCP-1 concentrations in maternal plasma could be used in the monitoring of kidney injury in preeclamptic women; however, there is a need to perform longitudinal studies. Here, CCL2 is linked to kidney injury.